Alber G., Kim K.-W., Weiser P., Riesterer C., Carsetti R., Reth M. (1993) Molecular mimicry of the antigen receptor signalling motif by transmembrane proteins of the Epstein-Barr virus and the bovine leukaemia virus. Curr. Biol. 3:333-339.
Beaufils P., Choquet D., Mamoun R.Z., Malissen B. (1993) The (YXXL/I)2 signaling motif found in the cytoplasmic segments of the bovine leukaemia virus envelope protein and Epstein-Barr virus latent membrane protein 2A can elicit early and late lymphocyte activation events. EMBO J. 12:5105-5112.
Bex F., Gaynor R.B. (1998) Regulation of gene expression by HTLV-1 Tax protein. Methods 16:83-94.
Burny A., Cleuter Y., Kettmann R., Mammerickx M., Marbaix G., Portetelle D., Van Den Broeke A., Willems L., Thomas R. (1988) Bovine leukemia: Facts and hypotheses derived from the study of an infectious cancer. Adv. Vet. Sci. Comp. Med. 32:149-170.
Cantor G.H. (1996) A potential proline-rich motif upstream of the immunoreceptor tyrosine-based activation motif in bovine leukemia virus gp30. Epstein-Barr virus LMP2A, herpesvirus papio LMP2A, and African horsesickness virus. Virology 220:265-266.
Cantor G.H., Pritchard S.M., Orlik O., Splitter G.A., Davis W.C., Reeves R. (1999) Bovine leukemia virus transmembrane protein gp30 physically associates with the down-regulatory phosphatase SHP-1. Cell. Immunol. 193:117-124.
Depelchin A., Letesson J.J., Lostrie-Trussart N., Mammerickx M., Portetelle D., Burny A. (1989) Bovine leukemia virus (BLV)-infected B-cells express a marker similar to the CD5 T-cell marker. Immunol. Lett. 20:69-76.
Dequiedt F., Cantor G.H., Hamilton V.T., Pritchard S.M., Davis W.C., Kerkhofs P., Burny A., Kettmann R., Willems L. (1999) Bovine leukemia virus-induced persistent lymphocytosis in cattle does not correlate with increased ex vivo survival of B lymphocytes. J. Virol. 73:1127-1137.
Dequiedt F., Hanon E., Kerkhofs P., Pastoret P.-P., Portetelle D., Burny A., Kettmann R., Willems L. (1997) Both wild-type and strongly attenuated bovine leukemia viruses protect peripheral blood mononuclear cells from apoptosis. J. Virol. 71:630-639.
Dettenhofer M., Yu X.F. (1999) Proline residues in human immunodeficiency virus type 1 p6(Gag) exert a cell type-dependent effect on viral replication and virion incorporation of Pol proteins. J. Virol. 73:4696-4704.
Fackler O.T., Luo W., Geyer M., Alberts A.S., Peterlin B.M. (1999) Activation of Vav by Nef induces cytoskeletal rearrangements and downstream effector functions. Mol. Cell 3:729-739.
Faux M.C., Scott J.D. (1996) Molecular glue: Kinase anchoring and scaffold proteins. Cell 85:9-12.
Hailata N., Johnson R., Al-Bagdadi F., Hanash S. (1995) Proliferating cell nuclear antigen expression in sheep infected with bovine leukemia virus. Vet. Immunol. Immunopath. 44:211-222.
Huang M., Orenstein J.M., Martin M.A., Freed E.O. (1995) p6Gag is required for particle production from full-length human immunodeficiency virus type 1 molecular clones expressing protease. J. Virol. 69:6810-6818.
Jayakar H.R., Gopal Murti K., Whitt M.A. (2000) Mutations in the PPPY motif of vesicular stomatitis virus matrix protein reduce virus budding by inhibiting a late step in virion release. J. Virol. 74:9818-9827.
Kay B.K., Williamson M.P., Sudol M. (2000) The importance of being proline: The interaction of proline-rich motifs in signaling proteins with their cognate domains. FASEB J. 14:231-241.
Kenyon S.J., Piper C.E. (1977) Cellular basis of persistent lymphocytosis in cattle infected with bovine leukemia virus. Infect. Immun. 16:891-897.
Mamoun R.Z., Morisson M., Rebeyrotte N., Busetta B., Couez D., Kettmann R., Hospital M., Guillemain B. (1990) Sequence variability of bovine leukemia virus env gene and its relevance to the structure and antigenicity of the glycoproteins. J. Virol. 64:4180-4188.
Pancio H.A., Vander Heyden N., Ratner L. (2000) The C-terminal proline-rich tail of human immunodeficiency virus type 2 vpx is necessary for nuclear localization of the viral preintegration complex in nondividing cells. J. Virol. 74:6162-6167.
Pawson T. (1995) Protein modules and signalling networks. Nature 373:573-580.
Portetelle D., Limbach K., Burny A., Mammerickx M., Desmettre P., Riviere M., Zavada J., Paoletti E. (1991) Recombinant vaccinia virus expression of the bovine leukaemia virus envelope gene and protection of immunized sheep against infection. Vaccine 9:194-200.
Portetelle D., Mammerickx M., Burny A. (1989) Use of two monoclonal antibodies in an ELISA test for the detection of antibodies to bovine leukaemia virus envelope protein gp51. J. Virol. Methods 23:211-222.
Reichert M., Grundboeck-Jusko J. (1991) Molecular cloning of provirus DNA from bovine leukaemia lymphocytes and its application as a probe for diagnostic purpose. Acta Biochim. Pol. 38:111-114.
Ren R., Mayer B.J., Cicchetti P., Baltimore D. (1993) Identification of a ten-amino acid proline-rich SH3 binding site. Science 259:1157-1161.
Reth M. (1989) Antigen receptor tail clue. Nature 338:383-384.
Rice N.R., Stephens R.M., Couez D., Deschamps J., Kettmann R., Burny A., Gilden R.V. (1984) The nucleotide sequence of the env gene and post-env region of bovine leukemia virus. Virology 138:82-93.
Saksela K., Cheng G., Baltimore D. (1995) Proline-rich (PxxP) motifs in HIV-1 Nef bind to SH3 domains of a subset of Src kinases and are required for the enhanced growth of Nef+ viruses but not for down-regulation of CD4. EMBO J. 14:484-491.
Shoya Y., Kobayashi T., Koda T., Ikuta K., Kakinuma M., Kishi M. (1998) Two proline-rich nuclear localization signals in the amino- and carboxyl-terminal regions of the Borna disease virus phosphoprotein. J. Virol. 72:9755-9762.
Willems L., Gatot J.S., Mammerickx M., Portetelle D., Burny A., Kerkhofs P., Kettmann R. (1995) The YXXL signalling motifs of the bovine leukemia virus transmembrane protein are required for in vivo infection and maintenance of high viral load. J. Virol. 69:4137-4141.
Willems L., Grimonpont C., Heremans H., Rebeyrotte N., Chen G., Portetelle D., Burny A., Kettmann R. (1992) Mutations in the bovine leukemia virus tax protein can abrogate the long terminal repeat-directed transactivating activity without concomitant loss of transforming potential. Proc. Natl. Acad. Sci. USA 89:3957-3961.
Willems L., Heremans H., Chen G., Portetelle D., Billiau A., Burny A., Kettmann R. (1990) Cooperation between bovine leukaemia virus transactivator protein and Ha-ras oncogene product in cellular transformation. EMBO J. 9:1577-1581.
Willems L., Portetelle D., Kerkhofs P., Chen G., Burny A., Mammerickx M., Kettmann R. (1992) In vivo transfection of bovine leukemia provirus into sheep. Virology 189:775-777.